EIF2AK3 and neoplasm: The PERK/ATF4 pathway is involved in the regulation of vascular endothelial growth factor expression as well as fibroblast growth factor-2 and interleukin-6 expression in glucose-deprived human tumor cells, resulting in facilitated angiogenesis [27].